These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23401136)

  • 1. Normal viability of Kai1/Cd82 deficient mice.
    Risinger JI; Custer M; Feigenbaum L; Simpson RM; Hoover SB; Webster JD; Chandramouli GV; Tessarollo L; Barrett JC
    Mol Carcinog; 2014 Aug; 53(8):610-24. PubMed ID: 23401136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
    Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
    Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.
    Christgen M; Christgen H; Heil C; Krech T; Länger F; Kreipe H; Lehmann U
    Cancer Sci; 2009 Sep; 100(9):1767-71. PubMed ID: 19549254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.
    Yusenko MV; Kovacs G
    Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
    Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
    Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: relationship to KAI1/CD82 levels and invasive behaviour.
    Rowe A; Jackson P
    Oncol Rep; 2006 Dec; 16(6):1267-72. PubMed ID: 17089048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression.
    Bandyopadhyay S; Zhan R; Chaudhuri A; Watabe M; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Pauza ME; Hayashi S; Wang Y; Mohinta S; Mashimo T; Iiizumi M; Furuta E; Watabe K
    Nat Med; 2006 Aug; 12(8):933-8. PubMed ID: 16862154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
    Malik FA; Sanders AJ; Jiang WG
    Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
    Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
    Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
    Guo C; Liu QG; Zhang L; Song T; Yang X
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
    Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
    Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
    Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
    Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancer.
    Knoener M; Krech T; Puls F; Lehmann U; Kreipe H; Christgen M
    Dis Markers; 2012; 32(6):337-42. PubMed ID: 22684230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82.
    Dodla P; Bhoopalan V; Khoo SK; Miranti C; Sridhar S
    BMC Cancer; 2020 Dec; 20(1):1211. PubMed ID: 33298014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
    Prabhu VV; Devaraj SN
    J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KAI1/CD82 Genetically Engineered Endothelial Progenitor Cells Inhibit Metastasis of Human Nasopharyngeal Carcinoma in a Mouse Model.
    Wang G; Zhang L; Zhou Y; Sun Q; Xu H; Cai F; Xiang P; Chen Z; Jiang H
    Med Sci Monit; 2018 May; 24():3146-3152. PubMed ID: 29755107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.